Document is current

Any future updates will be listed below

Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation

Crossref DOI link: https://doi.org/10.1007/s12032-016-0798-9

Published Online: 2016-07-04

Published Print: 2016-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark